Please join us November 11, 2022

This event has been reviewed and designated as a jointly accredited activity.

Attendees will be eligible to earn 6 AMA PRA Category 1 Credits.

Check out our agenda.

Visiting us from elsewhere and need lodgings?

Our partner hotel is the beautiful Washington Duke Inn and Golf Club.

 

Washington Duke

Scan this code for hotel information.

 

 

Session 1 begins at 9:00 am

John Wingard, MD, Price Eminent Scholar, Deputy Director of UF Health Cancer Center, and Professor of Medicine, University of Florida

Proteosome Inhibitors (Bortezomib, Carfilzomib) for Multiple Myeloma:  Mechanism of action, outcomes including duration of immunologic consequences.

Session 2 begins at 9:35 am

  Stuart J. Knechtle, MD, William R. Kenan, Jr. Distinguished Professor, Professor of Surgery, Executive Director, Duke Transplant Center, Duke University

Co-stimulation Blockade (Belatacept) + Proteosome Inhibition (Carfilzomib) for managing donor specific antibodies pre- and post-transplant.

Session 3 begins at 10:10 am

Jennifer H. Saullo, MD, PharmD, Assistant Professor of Medicine, Transplant Infectious Diseases, Duke University

Combining Immunologics:  prolonging survival or doubling trouble?

10:40 – 11:00 BREAK

Session 4 begins at 11:00 am

Jonathan Huggins, MD. MSCE, Assistant Professor of Medicine, Transplant Infectious Diseases, Duke University

Chimeric antigen receptor (CAR) T-cell therapy for Cancer:  Infectious Risk Including Long-term Sequela.

Session 5 begins at 11:35 am

Patrick Hanley, Ph. D. Chief and Director, Cellular Therapy Program, Associate Professor of Pediatrics, Children’s National Hospital, Washington, D.C.

Virus Specific T-cell Therapies after Transplantation:  Donor specific or Off-the-Shelf: efficacy, availability.

Session 6 begins at 12:10 pm

Garnett H. Kelsoe. DSc, James B. Duke Distinguished Professor of Immunology, Duke University

Back to Basics:  Deciphering immunologic impact and infectious risk in the laboratory; Measuring pathogen specific B memory and plasma cells to assess vaccine induced immunity and infection risk

Moderator/Event Host: Barbara D. Alexander, MD, MHA, FIDSA, Director, Transplant Infectious Diseases, Head, Clinical Mycology Laboratory, Professor of Medicine and Pathology, Duke University.

This event has been reviewed and designated as a jointly accredited activity. Attendees will be eligible to earn 6 AMA PRA Category 1 Credits.